251 related articles for article (PubMed ID: 11187878)
1. Hemophilia treatment. Side effects during immune tolerance induction.
Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
[No Abstract] [Full Text] [Related]
2. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to factor VIII in hemophilia A patients.
Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis in patients with hemophilia.
Jadhav M; Warrier I
Semin Thromb Hemost; 2000; 26(2):205-8. PubMed ID: 10919414
[TBL] [Abstract][Full Text] [Related]
5. The management of hemophilia patients with inhibitors.
Nilsson IM
Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
[No Abstract] [Full Text] [Related]
6. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
DiMichele D; Kroner B;
Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
[TBL] [Abstract][Full Text] [Related]
7. The treatment of factor VIII inhibitors--a general overview.
White GC; Roberts HR
Vox Sang; 1996; 70 Suppl 1():19-23. PubMed ID: 8869464
[TBL] [Abstract][Full Text] [Related]
8. Suggestions for the management of factor VIII inhibitors.
Rubinger M; Rivard GE; Teitel J; Walker H;
Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
[No Abstract] [Full Text] [Related]
9. Application of current knowledge to the management of bleeding events during immune tolerance induction.
Di Paola J; Aledort L; Britton H; Carcao M; Grabowski E; Hutter J; Journeycake J; Kempton C; Leissinger C
Haemophilia; 2006 Nov; 12(6):591-7. PubMed ID: 17083508
[TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance using porcine factor VIII.
Hay CR; Laurian Y
Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473
[No Abstract] [Full Text] [Related]
11. Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.
Ewing NP
Prog Clin Biol Res; 1990; 324():59-68. PubMed ID: 2106693
[No Abstract] [Full Text] [Related]
12. Inhibitors in haemophilia: a primer.
DiMichele DM
Haemophilia; 2000 Jul; 6 Suppl 1():38-40. PubMed ID: 10982266
[No Abstract] [Full Text] [Related]
13. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
Scandella D; Reyes H; Felch M; Sakurai Y
Haematologica; 2000 Oct; 85(10 Suppl):86-8. PubMed ID: 11187882
[TBL] [Abstract][Full Text] [Related]
14. Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor.
Mariani G; Brackmann HH
Haematologica; 2001 Mar; 86(3):225-6. PubMed ID: 11255267
[No Abstract] [Full Text] [Related]
15. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII brand and immunogenicity.
Ragni MV
Blood; 2014 Nov; 124(23):3337-8. PubMed ID: 25431473
[No Abstract] [Full Text] [Related]
17. Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry.
Kruse-Jarres R; Gilsenan A; Spears J; Kaye JA
Haemophilia; 2015 Mar; 21(2):e122-e124. PubMed ID: 25623889
[No Abstract] [Full Text] [Related]
18. Immune tolerance in haemophilia and the treatment of haemophiliacs with an inhibitor. Proceedings of the 2nd Workshop on Immune Tolerance. Bonn-Konigswinter, Germany, August 27-30, 1997.
Vox Sang; 1999; 77 Suppl 1():1-100. PubMed ID: 10644229
[No Abstract] [Full Text] [Related]
19. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH
Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781
[No Abstract] [Full Text] [Related]
20. Risk of inhibitors in previously untreated patients with hemophilia: a meta-analysis of literature studies.
Di Minno MN; Marchesini E; Valdrè L
Blood; 2015 Jun; 125(24):3819-21. PubMed ID: 26069336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
